HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Philip Bonomi Selected Research
Philip Bonomi Research Topics
Disease
46
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 02/2002
31
Neoplasms (Cancer)
08/2021 - 02/2002
13
Lung Neoplasms (Lung Cancer)
10/2019 - 02/2002
10
Disease Progression
06/2016 - 11/2006
5
Adenocarcinoma of Lung
12/2014 - 07/2010
3
Weight Gain
10/2019 - 11/2011
3
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2018 - 02/2002
2
Fibrosis (Cirrhosis)
01/2018 - 09/2005
2
Thrombocytopenia (Thrombopenia)
06/2016 - 03/2011
2
Adenocarcinoma
01/2014 - 10/2012
2
Lymphatic Metastasis
07/2011 - 03/2009
2
Neoplasm Metastasis (Metastasis)
07/2009 - 02/2002
1
Cardiovascular Diseases (Cardiovascular Disease)
08/2021
1
Atrial Fibrillation
08/2021
1
Sinus Tachycardia
08/2021
1
Pulmonary Embolism
08/2021
1
Left Ventricular Dysfunction
08/2021
1
Renal Cell Carcinoma (Grawitz Tumor)
01/2020
1
Cachexia
10/2019
1
Anorexia
10/2019
1
Inflammation (Inflammations)
01/2018
1
Circulating Neoplastic Cells
01/2018
1
Neutropenia
06/2016
1
Pathologic Complete Response
10/2015
1
Fatigue
02/2015
1
Peptic Ulcer (Peptic Ulcers)
04/2008
1
Gastrointestinal Hemorrhage (Hematochezia)
04/2008
Drug/Important Bio-Agent (IBA)
11
Biomarkers (Surrogate Marker)
IBA
01/2021 - 08/2004
6
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2018 - 08/2003
6
Pemetrexed (MTA)
FDA Link
05/2015 - 07/2006
6
Paclitaxel (Taxol)
FDA Link
Generic
05/2015 - 05/2006
5
Carboplatin (JM8)
FDA Link
Generic
05/2015 - 08/2007
5
Platinum
IBA
03/2015 - 02/2002
4
Gefitinib (Iressa)
FDA Link
01/2018 - 08/2003
4
Bevacizumab (Avastin)
FDA Link
05/2015 - 07/2009
4
Proteins (Proteins, Gene)
FDA Link
07/2013 - 03/2011
3
Autoantibodies
IBA
01/2021 - 07/2010
3
Cisplatin (Platino)
FDA Link
Generic
06/2016 - 02/2002
3
Paraffin
IBA
01/2014 - 05/2007
3
ErbB Receptors (EGF Receptor)
IBA
01/2014 - 08/2003
3
Cytotoxins (Cytolysins)
IBA
04/2007 - 08/2003
2
Immune Checkpoint Inhibitors
IBA
01/2021 - 01/2020
2
Autoantigens
IBA
01/2021 - 07/2011
2
Monoclonal Antibodies
IBA
10/2019 - 07/2008
2
Gemcitabine
FDA Link
06/2016 - 07/2006
2
Formaldehyde (Formol)
FDA Link
01/2014 - 12/2012
2
Insulin-Like Peptides
IBA
05/2012 - 11/2011
2
Tyrosine Kinase Inhibitors
IBA
05/2007 - 08/2003
2
paclitaxel poliglumex (XYOTAX)
IBA
04/2007 - 05/2006
1
Dihydrotachysterol (AT 10)
IBA
08/2021
1
Adenosine (Adenocard)
FDA Link
Generic
01/2020
1
Ghrelin
IBA
10/2019
1
Ado-Trastuzumab Emtansine
IBA
01/2019
1
Acute-Phase Proteins (Acute-Phase Protein)
IBA
01/2018
1
B7-H1 Antigen
IBA
01/2018
1
pembrolizumab
IBA
01/2018
1
necitumumab
IBA
06/2016
1
Ramucirumab
IBA
03/2015
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2015
1
Transcription Factors (Transcription Factor)
IBA
01/2014
1
src-Family Kinases
IBA
07/2013
1
Lipids
IBA
07/2013
1
Epidermal Growth Factor (EGF)
IBA
07/2013
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
07/2013
1
Heat-Shock Proteins (Heat-Shock Protein)
IBA
06/2013
1
STA 9090
IBA
06/2013
1
EC145
IBA
10/2012
1
Folic Acid (Vitamin M)
FDA Link
Generic
10/2012
1
Somatomedin Receptors (Somatomedin Receptor)
IBA
03/2012
1
C-Peptide
IBA
11/2011
1
Insulin-Like Growth Factor I (IGF-1)
IBA
11/2011
1
Insulin-Like Growth Factor Binding Proteins
IBA
11/2011
1
navitoclax
IBA
03/2011
1
big gastrin
IBA
03/2011
1
Peptides (Polypeptides)
IBA
03/2011
1
Xanthine Dehydrogenase
IBA
02/2011
1
Albumins
IBA
07/2009
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
07/2009
1
denileukin diftitox (Ontak)
FDA Link
06/2009
1
mapatumumab
IBA
07/2008
1
Celecoxib (Celebrex)
FDA Link
04/2008
1
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
IBA
04/2008
1
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
04/2008
1
ixabepilone (BMS 247550)
FDA Link
08/2007
1
epothilone B (EPO906)
IBA
08/2007
1
taxane
IBA
08/2007
1
Taxoids (Taxanes)
IBA
04/2007
1
Docetaxel (Taxotere)
FDA Link
04/2007
1
Polymers
IBA
04/2007
Therapy/Procedure
23
Therapeutics
01/2020 - 02/2002
16
Drug Therapy (Chemotherapy)
01/2021 - 02/2002
5
Chemoradiotherapy
12/2015 - 06/2011
3
Immunotherapy
01/2021 - 10/2019
3
Radiotherapy
09/2014 - 09/2005
2
Neoadjuvant Therapy
10/2013 - 07/2011
1
Ambulatory Care (Outpatient Care)
08/2021
1
Precision Medicine
08/2017
1
Intravenous Infusions
06/2013
1
Pneumonectomy (Lung Volume Reduction)
09/2009
1
Combination Drug Therapy (Combination Chemotherapy)
07/2009